Chemical Importer Opposes Anti-Dumping Order At CIT

Law360, New York (November 14, 2017, 12:33 PM EST) -- Pharm-Rx Chemical Corp. has contested the International Trade Administration's decision backing an anti-dumping duty order on imports of glycine from the People’s Republic of China in the Court of International Trade, according to court documents filed on Monday.

Specifically, Pharm-Rx filed a summons with the CIT a month after the U.S. Department of Commerce issued its final determination confirming that the company’s Chinese supplier of glycine, Jizhou City Huayang Chemical Co. Ltd., was subject to the PRC-wide anti-dumping rate of nearly 454 percent.

Commerce determined in...
To view the full article, register now.